Pamala buys BMRN 58.44: BioMarin to Present at the Bank of America Merrill Lynch 2014 Healthcare Conference on May 14th and the UBS Global Healthcare Co ...
SAN RAFAEL, Calif., May 6, 2014 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN), a global leader in the development and commercialization of therapies for rare genetic diseases, today announced that Dan Spiegelman, Executive Vice President . ... ...
51 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home